 |
|
|
| |
The efficacy and safety of the interferon-free combination of BI 201335 and BI 207127 in genotype 1 HCV patients with cirrhosis: Interim analysis from SOUND-C2
|
| |
| |
Reported by Jules Levin
EASL 2012 April 18-22 Barcelona Spain
Vicente Soriano,1 Ed Gane,2 Peter Angus,3 Felix Stickel,4 Jean-Pierre Bronowicki,5 Stuart Roberts,6 Michael Manns,7 Stefan Zeuzem,8 Luyan Dai,9 Wulf Boecher,10 Jerry Stern9 and Federico Mensa9
1Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain; 2Auckland Clinical Studies, Auckland, New Zealand; 3Austin Health, Liver Transplant Unit, Heidelberg, Australia; 4Universitätsklinik für Viszerale Chirurgie und Medizin, Bern, Switzerland; 5Hopital de Brabois, Vandoeuvre, France; 6Alfred Hospital, Department of Gastroenterology, Melbourne, Australia;
7Medizinische Hochschule Hannover, Hannover, Germany; 8Klinikum der J. W. Goethe-Universität, Frankfurt am Main, Germany; 9Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA; 10Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
|
| |
|
|
|
|
|
